-
Mar 27, 2024
Helping to change to trajectory of obesity and chronic disease is good for employers’ and for employees’ health and saves the health system money. Moreover, people with...
-
Mar 14, 2024
Drug development is expensive and failure is the norm. As a result, drug companies, investors and academic institutions are forced to make choices about how to spend money and time....
-
Jan 23, 2024
The Biden administration and members of Congress have proposed reducing protections on intellectual property to lower drug prices. However, these policies could affect academic...
-
Jan 22, 2024
The Biden administration and members of Congress have proposed reducing protections on intellectual property to lower drug prices. However, these policies could affect academic...
-
Jan 18, 2024
The Biden administration and members of Congress have proposed reducing protections on intellectual property to lower drug prices. However, these policies could affect academic...
-
Jan 17, 2024
The Biden administration and members of Congress have proposed reducing protections on intellectual property to lower drug prices. However, these policies could affect academic...
-
Jan 8, 2024
At a webinar hosted by RealClearHealth, I spoke on how “vaccines are one of the few truly cost-effective health care interventions.” When evaluated across a range of...